Tourbillon's Karp says Sarepta shares could surge 200 pct
May 18, 2017 at 14:44 PM EDT
LAS VEGAS, May 18 (Reuters) - Hedge fund manager Jason Karp on Thursday said that shares of Sarepta Therapeutics Inc could climb as much as 200 percent and noted the biotech company could be an attractive takeover candidate.
